Literature DB >> 15503084

Current concepts and applications of coronary venous retroinfusion.

Peter Boekstegers1, Christian Kupatt.   

Abstract

Retroinfusion of the coronary veins has gained attention for therapeutic approaches which target drugs, genes or cells to ischemic myocardium. Besides anatomy of the coronary venous system, the pressure flow relationship during retroinfusion and the efficacy of pressure-regulated selective retroinfusion for targeted delivery of drugs is reported. Moreover, we describe adenoviral and liposomal gene transfer into ischemic and nonischemic myocardium, outline studies in chronic ischemic preclinical models treated by retroinfusion of pro-angiogenic agents and discuss the impact of retroinfusion for cell-based regenerative therapy of the diseased myocardium.

Entities:  

Mesh:

Year:  2004        PMID: 15503084     DOI: 10.1007/s00395-004-0486-3

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  9 in total

Review 1.  Delivery of gene and cellular therapies for heart disease.

Authors:  Justin A Mariani; David M Kaye
Journal:  J Cardiovasc Transl Res       Date:  2010-05-11       Impact factor: 4.132

Review 2.  Percutaneous approaches for efficient cardiac gene delivery.

Authors:  Kiyotake Ishikawa; Jaume Aguero; Charbel Naim; Kenneth Fish; Roger J Hajjar
Journal:  J Cardiovasc Transl Res       Date:  2013-06-08       Impact factor: 4.132

Review 3.  Cardiac gene therapy: optimization of gene delivery techniques in vivo.

Authors:  Michael G Katz; JaBaris D Swain; Jennifer D White; David Low; Hansell Stedman; Charles R Bridges
Journal:  Hum Gene Ther       Date:  2010-04       Impact factor: 5.695

4.  Technique of Complete Heart Isolation with Continuous Cardiac Perfusion During Cardiopulmonary Bypass: New Opportunities for Gene Therapy.

Authors:  Michael G Katz; Anthony S Fargnoli; Charles Yarnall; Angel Perez; Alice Isidro; Roger J Hajjar; Charles R Bridges
Journal:  J Extra Corpor Technol       Date:  2018-09

5.  A needleless liquid jet injection delivery method for cardiac gene therapy: a comparative evaluation versus standard routes of delivery reveals enhanced therapeutic retention and cardiac specific gene expression.

Authors:  A S Fargnoli; M G Katz; R D Williams; K B Margulies; Charles R Bridges
Journal:  J Cardiovasc Transl Res       Date:  2014-10-15       Impact factor: 4.132

Review 6.  Current strategies for myocardial gene delivery.

Authors:  Michael G Katz; JaBaris D Swain; Catherine E Tomasulo; Marina Sumaroka; Anthony Fargnoli; Charles R Bridges
Journal:  J Mol Cell Cardiol       Date:  2010-09-15       Impact factor: 5.000

Review 7.  Gene delivery technologies for cardiac applications.

Authors:  M G Katz; A S Fargnoli; L A Pritchette; C R Bridges
Journal:  Gene Ther       Date:  2012-03-15       Impact factor: 5.250

Review 8.  Gene and cell therapy for heart failure.

Authors:  Ebo D de Muinck
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

9.  In Situ Heart Isolation Featuring Closed Loop Recirculation: The Gold Standard for Optimum Cardiac Gene Transfer?

Authors:  Michael G Katz; Anthony S Fargnoli; Roger J Hajjar; Charles R Bridges
Journal:  Adv Tech Biol Med       Date:  2017-10-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.